Re: Confidence intervals of PsN bootstrap output
Nick, Jakob, nmusers:
At the risk of re-opening an old discussion, I'd like to expand on Nick's
important point. From our experience the experience of others, including
parameters from all bootstrap runs that report parameter estimates, regardless
of minimization of $COV status, is a reasonable thing to do; provided that the
modeler conducts a careful and thoughtful evaluation of the model and bootstrap
results.
One goal should be to understand why minimization, $COV, or boundary problems
occur. For example, it is useful to create histograms and a scatterplot matrix
of the resulting bootstrap parameter distributions, flagging those runs with
minimization problems. Most of the time, these problematic runs represent the
tails of the distribution for a less precisely defined parameter. Sometimes the
boundary message is just a reflection of the tail of a bootstrap parameter
distribution approaching the null value for that parameter. All of these runs
are informative about the estimation precision and should be included.
This is not always the case, however. In fact, even successful minimization and
$COV do not guarantee that the resulting parameter estimates should be included
in bootstrap confidence intervals. For example, bootstrapping is often a useful
way to identify models with more than 1 unique solution (e.g. flip-flop in PK
rate constants). In addition, some runs may represent a local minimum. Another
problem can arise if the bootstrap resampling is not stratified on the major
covariate(s) or design features of the original data set (e.g. pooled analyses
of adult studies and pediatric studies, or pooled analyses of sparsely sampled
and extensively sampled studies). In all of these cases, the histograms and
scatterplot matrices may reveal a multimodal "posterior" bootstrap distribution
for some of the parameters, which should be addressed before using bootstrap
results for inferential or simulation purposes.
Obviously, it's important for the modeler to think about the problem and to
understand what the results mean. Blindly accepting or rejecting runs based on
a software warning message, or on another scientist's R script, is not
advisable.
Best regards,
Marc
Marc R. Gastonguay, Ph.D. ([email protected])
President & CEO, Metrum Research Group LLC (metrumrg.com)
Scientific Director, Metrum Institute (metruminstitute.org)
Quoted reply history
On Saturday, July 9, 2011 at 9:14 AM, Nick Holford wrote:
> Jakob,
>
> Thanks for your helpful comments. I agree with you that any results that
> are at a boundary should be discarded from the bootstrap distribution.
>
> Although you say you do not wish to re-open the discussion, there is
> evidence that discarding other non-successful runs makes no difference
> to the parameter distribution (Gastonguay & El-Tahtawy 2005, Holford et
> al. 2006) and also makes no difference to model selection results when
> estimating from simulated data (Byon et al 2008, Ahn et al 2008). While
> these conclusions may be controversial it is a controversy with evidence
> only on the side of those who say all bootstrap results may be used to
> describe the distribution versus speculation from those who say they
> should be discarded. Perhaps there is some new evidence from the
> speculators that could further enlighten the discussion?
>
> Nick
>
>
> Gastonguay G, El-Tahtawy A. Minimization status had minimal impact on
> the resulting BS [bootstrap] parameter distributions
> http://metrumrg.com/publications/Gastonguay.BSMin.ASCPT2005.pdf In:
> ASCPT, 2005.
> Holford NHG, Kirkpatrick C, Duffull S. NONMEM Termination Status is Not
> an Important Indicator of the Quality of Bootstrap Parameter Estimates
> http://www.page-meeting.org/default.asp?abstract=992. In: PAGE, Bruges,
> 2006.
> Byon W, Fletcher CV, Brundage RC. Impact of censoring data below an
> arbitrary quantification limit on structural model misspecification. J
> Pharmacokinet Pharmacodyn. 2008;35(1):101-16.
> Ahn JE, Karlsson MO, Dunne A, Ludden TM. Likelihood based approaches to
> handling data below the quantification limit using NONMEM VI. J
> Pharmacokinet Pharmacodyn. 2008;35(4):401-21.
>